- North Star Asset Management Inc. purchased a new stake of 25,780 shares in 10x Genomics valued at approximately $988,000 during the second quarter.
- Institutional investors and hedge funds currently own 84.68% of the company's stock, alongside recent notable insider share sales.
- 10x Genomics reported a quarterly revenue of $151.04 million and earnings per share of ($0.14), outperforming consensus estimates.